Pharma's Almanac

Mobile Navigation

Subscribe for the Newsletter

Articles
Expert Interviews
Roundtable
Press Releases
Videos

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Crohn's Disease

Sort By

1 / 1

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Our Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2025 PHARMA’S ALMANAC. All rights reserved.

1 / 1

Crohn's Disease

Theravance Biopharma Announces First Patient Dosed in Phase 2 Study of TD-1473 in Patients with Crohn's Disease

Theravance Biopharma

PR-M11-18-NI-092Nov 27, 2018

ResearchandMarkets

Market Prediction

Global Crohn's Disease Therapeutics Market to 2025 with Johnson & Johnson Services Inc. Pfizer Inc. Allergan and AbbVie Dominating

ResearchandMarkets

PR-M11-18-NI-049Nov 14, 2018